Q-Codes
Q9000–Q9999: Temporary Codes
Q9000–Q9999
- Q9001Assessment by chaplain services
- Q9002Counseling, individual, by chaplain services
- Q9003Counseling, group, by chaplain services
- Q9004Department of veterans affairs whole health partner services
- Q9950Injection, sulfur hexafluoride lipid microspheres, per ml
- Q9951Low osmolar contrast material, 400 or greater mg/ml iodine concentration, per ml
- Q9953Injection, iron-based magnetic resonance contrast agent, per ml
- Q9954Oral magnetic resonance contrast agent, per 100 ml
- Q9955Injection, perflexane lipid microspheres, per ml
- Q9956Injection, octafluoropropane microspheres, per ml
- Q9957Injection, perflutren lipid microspheres, per ml
- Q9958High osmolar contrast material, up to 149 mg/ml iodine concentration, per ml
- Q9959High osmolar contrast material, 150-199 mg/ml iodine concentration, per ml
- Q9960High osmolar contrast material, 200-249 mg/ml iodine concentration, per ml
- Q9961High osmolar contrast material, 250-299 mg/ml iodine concentration, per ml
- Q9962High osmolar contrast material, 300-349 mg/ml iodine concentration, per ml
- Q9963High osmolar contrast material, 350-399 mg/ml iodine concentration, per ml
- Q9964High osmolar contrast material, 400 or greater mg/ml iodine concentration, per ml
- Q9965Low osmolar contrast material, 100-199 mg/ml iodine concentration, per ml
- Q9966Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml
- Q9967Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml
- Q9968Injection, non-radioactive, non-contrast, visualization adjunct (e.g., methylene blue, isosulfan blue), 1 mg
- Q9969Tc-99m from non-highly enriched uranium source, full cost recovery add-on, per study dose
- Q9970Injection, ferric carboxymaltose, 1mg
- Q9972Injection, epoetin beta, 1 microgram, (for esrd on dialysis)
- Q9973Injection, epoetin beta, 1 microgram, (non-esrd use)
- Q9974Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg
- Q9975Injection, factor viii fc fusion protein (recombinant), per iu
- Q9976Injection, ferric pyrophosphate citrate solution, 0.1 mg of iron
- Q9977Compounded drug, not otherwise classified
- Q9978Netupitant 300 mg and palonosetron 0.5 mg
- Q9979Injection, alemtuzumab, 1 mg
- Q9980Hyaluronan or derivative, genvisc 850, for intra-articular injection, 1 mg
- Q9981Rolapitant, oral, 1 mg
- Q9982Flutemetamol f18, diagnostic, per study dose, up to 5 millicuries
- Q9983Florbetaben f18, diagnostic, per study dose, up to 8.1 millicuries
- Q9984Levonorgestrel-releasing intrauterine contraceptive system (kyleena), 19.5 mg
- Q9985Injection, hydroxyprogesterone caproate, not otherwise specified, 10 mg
- Q9986Injection, hydroxyprogesterone caproate, (makena), 10 mg
- Q9987Pathogen(s) test for platelets
- Q9988Platelets, pheresis, pathogen-reduced, each unit
- Q9989Ustekinumab, for intravenous injection, 1 mg
- Q9991Injection, buprenorphine extended-release (sublocade), less than or equal to 100 mg
- Q9992Injection, buprenorphine extended-release (sublocade), greater than 100 mg
- Q9993Injection, triamcinolone acetonide, preservative-free, extended-release, microsphere formulation, 1 mg
- Q9994In-line cartridge containing digestive enzyme(s) for enteral feeding, each
- Q9995Injection, emicizumab-kxwh, 0.5 mg
- Q9996Injection, ustekinumab-ttwe (pyzchiva), subcutaneous, 1 mg
- Q9997Injection, ustekinumab-ttwe (pyzchiva), intravenous, 1 mg
- Q9998Injection, ustekinumab-aekn (selarsdi), biosimilar, 1 mg
- Q9999Injection, ustekinumab-aauz (otulfi), biosimilar, 1 mg